SCHEMBL17437495

SCHEMBL17437495

Nc1ncnn1-c1nc2cnccc2n1CCc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR3A P46098 2/20 0.41
▸ RPS6KA5 O75582 3/20 0.39
▸ ADORA2A P29274 1/20 0.39
▸ ADORA1 P30542 1/20 0.39
▸ POLB P06746 2/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ LMNA P02545 2/20 0.38
▸ USP2 O75604 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ RECQL P46063 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ BRD4 O60885 1/20 0.37
▸ ATM Q13315 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17437535 0.89 BRD4 (0.43) HTR3ARPS6KA5ADORA2AADORA1POLB
SCHEMBL17437404 0.84 RPS6KA5 (0.47) RPS6KA5POLBLMNAMAPTATM
SCHEMBL17437386 0.79 RPS6KA5 (0.49) RPS6KA5MEN1KMT2AUSP2CYP1A2
SCHEMBL17437408 0.78 RPS6KA5 (0.41) HTR3ARPS6KA5ADORA2AADORA1POLB
SCHEMBL17437439 0.78 RPS6KA5 (0.45) RPS6KA5ADORA2AADORA1POLBLMNA
SCHEMBL17437575 0.71 RPS6KA5 (0.48) RPS6KA5CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL17437517 0.70 RPS6KA5 (0.37) RPS6KA5ATM
SCHEMBL17437519 0.70 RPS6KA5 (0.37) RPS6KA5ATM
SCHEMBL17437462 0.70 LTB4R (0.33) RPS6KA5ADORA2AADORA1MEN1KMT2A
SCHEMBL17437385 0.68 RPS6KA5 (0.51) RPS6KA5ADORA2AADORA1CYP2D6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2017-02-23 — — US disclosed
US-9512120-B2 Microbicidally active imidazopyridine derivatives SYNGENTA PARTICIPATIONS AG (CH) 2016-12-06 — — US disclosed
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2016-01-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170050963-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 HTR3A 1542/4885RPS6KA5 2731/4885ADORA2A 2060/4885
US-20160016949-A1 MICROBICIDALLY ACTIVE IMIDAZOPYRIDINE DERIVATIVES IDO1, IDO2, FOXM1 HTR3A 1542/4885RPS6KA5 2731/4885ADORA2A 2060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback